The State Of The Clinical Development Race

Every medicine reaches a patient after running a long race. It starts on a crowded grid of thousands of candidates, survives the punishing circuit of clinical development where most retire before the finish, and becomes one of only a rare few that ever reach the podium of a market launch.

From lights out to the checkered flag, this dispatch draws on three of Citeline’s core reports to tell a single story on how the field lined up, how the season was run, and who finished on top. From the starting grid to the podium, one pattern holds: The industry is becoming more selective, trading volume for precision.